The FDA has approved Triferic (soluble ferric pyrophosphate citrate), from Rockwell Medical, for commercial sale as an iron replacement product...
Rockwell Medical has announced that its New Drug Application (NDA) for Triferic (soluble ferric pyrophosphate citrate) has been accepted for...
Rockwell Medical, Inc. a fully-integrated biopharmaceutical company targeting End-Stage Renal Disease and Chronic Kidney Disease with innovative products and services...
Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative...